Solicitation TopicAward DateBioMaP-Consortium Member AwardedAward CeilingFocus Area
RPP-24-03-SterilizationSterilization Capacity for Vaccines and Therapeutics03/26/2025Steri-Tek LLC$12,776,831Industrial Base Expansion of Supply Chain
RPP-24-06-PipetteIndustrial Base Expansion of injection molded pipette tips and centrifuge tubes for use in the vaccine manufacturing and pandemic response supply chain03/14/2025Corning, Inc.$14,022,490Industrial Base Expansion of Supply Chain
RPP-24-03-SterilizationSterilization Capacity for Vaccines and Therapeutics03/07/2025Sterigenics Radiation Technologies LLC$9,243,129Industrial Base Expansion of Supply Chain
RPP-24-01-Small MolProduction of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale09/24/2024Amyris, Inc.$12,325,400Advanced Biomanufacturing Technologies
RPP-24-02-KSM-APIProduction of Drug Substances and Drug Products at Commercial Scale09/30/2024Resilience Government Services$17,496,354Advanced Biomanufacturing Technologies
RPP-24-02-KSM-APIProduction of Drug Substances and Drug Products at Commercial Scale11/25/2024Manus Bio, Inc.$32,394,626Advanced Biomanufacturing Technologies
RPP-24-02-KSM-APIProduction of Drug Substances and Drug Products at Commercial Scale11/25/2024Antheia, Inc.$11,958,014Advanced Biomanufacturing Technologies
RPP-24-02-KSM-APIProduction of Drug Substances and Drug Products at Commercial Scale09/11/2024API Innovation Center$13,968,691Advanced Biomanufacturing Technologies
RPP-24-03-SterilizationSterilization Capacity for Vaccines and Therapeutics08/22/2024Meissner Filtration Products, Inc.$11,678,000Industrial Base Expansion of Supply Chain
RPP-24-01-Small MolProduction of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale07/12/2024Capra Biosciences, Inc.$7,499,615Advanced Biomanufacturing Technologies
RPP-24-01-Small MolProduction of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale07/15/2024Antheia, Inc.$11,089,240Advanced Biomanufacturing Technologies